• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Theradaptive Secures $26M in Series A Funding to Advance Targeted Regenerative Therapeutics

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 16, 2023 at 10:32: AM
via Theradaptive, a Frederick, MD-based biopharmaceutical company focused on targeted regenerative therapeutics, raised $26M in Series A funding.

The round brought the total funding to over $50M. The backers were not disclosed.

article source
 




Top Bottom
Back
Quote